{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:50:16Z","timestamp":1791028216139,"version":"4.1.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,14]]},"DOI":"10.7759\/cureus.16388","type":"journal-article","created":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T16:54:17Z","timestamp":1626281657000},"source":"Crossref","is-referenced-by-count":39,"title":["Secondary Hyperparathyroidism in Chronic Kidney Disease: Pathophysiology and Management"],"prefix":"10.7759","author":[{"given":"Elmukhtar","family":"Habas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Eledrisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahmi","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdel-Naser Y","family":"Elzouki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1210\/er.2003-0024","article-title":"Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl- terminal ligands","volume":"26","author":"Murray TM","year":"2005","unstructured":"Murray TM, Rao LG, Divieti P, Bringhurst FR. Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl- terminal ligands. Endocr Rev. 2005, 26:78-113. 10.1210\/er.2003-0024","journal-title":"Endocr Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00608.2009","article-title":"Physiology and pathophysiology of the calcium-sensing receptor in the kidney","volume":"298","author":"Riccardi D","year":"2010","unstructured":"Riccardi D, Brown EM. Physiology and pathophysiology of the calcium-sensing receptor in the kidney. Am J Physiol Renal Physiol. 2010, 298:F485-99. 10.1152\/ajprenal.00608.2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/366575a0","article-title":"Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid","volume":"366","author":"Brown EM","year":"1993","unstructured":"Brown EM, Gamba G, Riccardi D, et al.. Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature. 1993, 366:575-80. 10.1038\/366575a0","journal-title":"Nature"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199507273330407","article-title":"Calcium-ion-sensing cell-surface receptors","volume":"333","author":"Brown EM","year":"1995","unstructured":"Brown EM, Pollak M, Seidman CE, Seidman JG, Chou YH, Riccardi D, Hebert SC. Calcium-ion-sensing cell-surface receptors. N Engl J Med. 1995, 333:234-40. 10.1056\/NEJM199507273330407","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00336.2004","article-title":"Vitamin D","volume":"289","author":"Dusso AS","year":"2005","unstructured":"Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol. 2005, 289:F8-28. 10.1152\/ajprenal.00336.2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1172\/JCI36479","article-title":"Endocrine functions of bone in mineral metabolism regulation","volume":"118","author":"Quarles LD","year":"2008","unstructured":"Quarles LD. Endocrine functions of bone in mineral metabolism regulation. J Clin Invest. 2008, 118:3820-8. 10.1172\/JCI36479","journal-title":"J Clin Invest"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0b013e328303e172","article-title":"Fibroblast growth factor 23 acts on the parathyroid to decrease parathyroid hormone secretion","volume":"17","author":"Galitzer H","year":"2008","unstructured":"Galitzer H, Ben-Dov I, Lavi-Moshayoff V, Naveh-Many T, Silver J. Fibroblast growth factor 23 acts on the parathyroid to decrease parathyroid hormone secretion. Curr Opin Nephrol Hypertens. 2008, 17:363-7. 10.1097\/MNH.0b013e328303e172","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.09501.x","article-title":"Regulation of PTH synthesis and secretion relevant to the management of secondary hyperparathyroidism in chronic kidney disease","author":"Silver J","year":"2005","unstructured":"Silver J, Levi R. Regulation of PTH synthesis and secretion relevant to the management of secondary hyperparathyroidism in chronic kidney disease. Kidney Int Suppl. 2005, S8-12. 10.1111\/j.1523-1755.2005.09501.x","journal-title":"Kidney Int Suppl"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016090944","article-title":"The pas de trois of vitamin D, FGF23, and PTH","volume":"28","author":"Naveh-Many T","year":"2017","unstructured":"Naveh-Many T, Silver J. The pas de trois of vitamin D, FGF23, and PTH. J Am Soc Nephrol. 2017, 28:393-5. 10.1681\/ASN.2016090944","journal-title":"J Am Soc Nephrol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2010020186","article-title":"The regulation of parathyroid hormone secretion and synthesis","volume":"22","author":"Kumar R","year":"2011","unstructured":"Kumar R, Thompson JR. The regulation of parathyroid hormone secretion and synthesis. J Am Soc Nephrol. 2011, 22:216-24. 10.1681\/ASN.2010020186","journal-title":"J Am Soc Nephrol"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.1093\/oxfordjournals.ndt.a027665","article-title":"A direct effect in vitro of phosphate on PTH release from bovine parathyroid tissue slices but not from dispersed parathyroid cells","volume":"11","author":"Nielsen PK","year":"1996","unstructured":"Nielsen PK, Feldt-Rasmussen U, Olgaard K. A direct effect in vitro of phosphate on PTH release from bovine parathyroid tissue slices but not from dispersed parathyroid cells. Nephrol Dial Transplant. 1996, 11:1762-8.","journal-title":"Nephrol Dial Transplant"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650110714","article-title":"Direct effect of phosphorus on PTH secretion from whole rat parathyroid glands in vitro","volume":"11","author":"Almaden Y","year":"1996","unstructured":"Almaden Y, Canalejo A, Hernandez A, Ballesteros E, Garcia-Navarro S, Torres A, Rodriguez M. Direct effect of phosphorus on PTH secretion from whole rat parathyroid glands in vitro. J Bone Miner Res. 1996, 11:970-6. 10.1002\/jbmr.5650110714","journal-title":"J Bone Miner Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118224","article-title":"Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D","volume":"96","author":"Naveh-Many T","year":"1995","unstructured":"Naveh-Many T, Rahamimov R, Livni N, Silver J. Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D. J Clin Invest. 1995, 96:1786-93. 10.1172\/JCI118224","journal-title":"J Clin Invest"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12399-9","article-title":"Phosphate acts directly on the calcium-sensing receptor to stimulate parathyroid hormone secretion","volume":"10","author":"Centeno PP","year":"2019","unstructured":"Centeno PP, Herberger A, Mun HC, et al.. Phosphate acts directly on the calcium-sensing receptor to stimulate parathyroid hormone secretion. Nat Commun. 2019, 10:4693. 10.1038\/s41467-019-12399-9","journal-title":"Nat Commun"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1172\/JCI32409","article-title":"The parathyroid is a target organ for FGF23 in rats","volume":"117","author":"Ben-Dov IZ","year":"2007","unstructured":"Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V, et al.. The parathyroid is a target organ for FGF23 in rats. J Clin Invest. 2007, 117:4003-8. 10.1172\/JCI32409","journal-title":"J Clin Invest"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1677\/JOE-07-0267","article-title":"Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells","volume":"195","author":"Krajisnik T","year":"2007","unstructured":"Krajisnik T, Bj\u00f6rklund P, Marsell R, et al.. Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells. J Endocrinol. 2007, 195:125-31. 10.1677\/JOE-07-0267","journal-title":"J Endocrinol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1172\/JCI106517","article-title":"On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog","volume":"50","author":"Slatopolsky E","year":"1971","unstructured":"Slatopolsky E, Caglar S, Pennell JP, Taggart DD, Canterbury JM, Reiss E, Bricker NS. On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog. J Clin Invest. 1971, 50:492-9. 10.1172\/JCI106517","journal-title":"J Clin Invest"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/0272-6386(95)90541-3","article-title":"Secondary hyperparathyroidism in renal failure: the trade-off hypothesis revisited","volume":"25","author":"Llach F","year":"1995","unstructured":"Llach F. Secondary hyperparathyroidism in renal failure: the trade-off hypothesis revisited. Am J Kidney Dis. 1995, 25:663-79. 10.1016\/0272-6386(95)90541-3","journal-title":"Am J Kidney Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-018-0486-0","article-title":"CKD-MBD: from the pathogenesis to the identification and development of potential novel therapeutic targets","volume":"16","author":"Elias RM","year":"2018","unstructured":"Elias RM, Dalboni MA, Coelho AC, Moys\u00e9s RM. CKD-MBD: from the pathogenesis to the identification and development of potential novel therapeutic targets. Curr Osteoporos Rep. 2018, 16:693-702. 10.1007\/s11914-018-0486-0","journal-title":"Curr Osteoporos Rep"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.215","article-title":"Parathyroid hormone activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription","volume":"86","author":"Meir T","year":"2014","unstructured":"Meir T, Durlacher K, Pan Z, Amir G, Richards WG, Silver J, Naveh-Many T. Parathyroid hormone activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription. Kidney Int. 2014, 86:1106-15. 10.1038\/ki.2014.215","journal-title":"Kidney Int"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada T","year":"2004","unstructured":"Shimada T, Hasegawa H, Yamazaki Y, et al.. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res. 2004, 19:429-35. 10.1359\/JBMR.0301264","journal-title":"J Bone Miner Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-018-0078-3","article-title":"The Klotho proteins in health and disease","volume":"15","author":"Kuro-O M","year":"2019","unstructured":"Kuro-O M. The Klotho proteins in health and disease. Nat Rev Nephrol. 2019, 15:27-44. 10.1038\/s41581-018-0078-3","journal-title":"Nat Rev Nephrol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/36285","article-title":"Mutation of the mouse klotho gene leads to a syndrome resembling ageing","volume":"390","author":"Kuro-o M","year":"1997","unstructured":"Kuro-o M, Matsumura Y, Aizawa H, et al.. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997, 390:45-51. 10.1038\/36285","journal-title":"Nature"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1096\/fj.08-114397","article-title":"In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis","volume":"23","author":"Nakatani T","year":"2009","unstructured":"Nakatani T, Sarraj B, Ohnishi M, et al.. In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis. FASEB J. 2009, 23:433-41. 10.1096\/fj.08-114397","journal-title":"FASEB J"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1096\/fj.10-154765","article-title":"Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule","volume":"24","author":"Hu MC","year":"2010","unstructured":"Hu MC, Shi M, Zhang J, et al.. Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule. FASEB J. 2010, 24:3438-50. 10.1096\/fj.10-154765","journal-title":"FASEB J"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease","volume":"16","author":"Gutierrez O","year":"2005","unstructured":"Gutierrez O, Isakova T, Rhee E, et al.. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol. 2005, 16:2205-15. 10.1681\/ASN.2005010052","journal-title":"J Am Soc Nephrol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016050585","article-title":"Let-7 and microRNA-148 regulate parathyroid hormone levels in secondary hyperparathyroidism","volume":"28","author":"Shilo V","year":"2017","unstructured":"Shilo V, Mor-Yosef Levi I, Abel R, Mihailovi\u0107 A, Wasserman G, Naveh-Many T, Ben-Dov IZ. Let-7 and microRNA-148 regulate parathyroid hormone levels in secondary hyperparathyroidism. J Am Soc Nephrol. 2017, 28:2353-63. 10.1681\/ASN.2016050585","journal-title":"J Am Soc Nephrol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.260","article-title":"Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients","volume":"78","author":"Krajisnik T","year":"2010","unstructured":"Krajisnik T, Olauson H, Mirza MA, et al.. Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients. Kidney Int. 2010, 78:1024-32. 10.1038\/ki.2010.260","journal-title":"Kidney Int"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-010-1565-3","article-title":"FGF23 and the parathyroid glands","volume":"25","author":"Silver J","year":"2010","unstructured":"Silver J, Naveh-Many T. FGF23 and the parathyroid glands. Pediatr Nephrol. 2010, 25:2241-5. 10.1007\/s00467-010-1565-3","journal-title":"Pediatr Nephrol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/184321","article-title":"International burden of chronic kidney disease and secondary hyperparathyroidism: a systematic review of the literature and available data","volume":"2015","author":"Hedgeman E","year":"2015","unstructured":"Hedgeman E, Lipworth L, Lowe K, Saran R, Do T, Fryzek J. International burden of chronic kidney disease and secondary hyperparathyroidism: a systematic review of the literature and available data. Int J Nephrol. 2015, 2015:184321. 10.1155\/2015\/184321","journal-title":"Int J Nephrol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2009.188","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","year":"2009","unstructured":"Kidney Disease. Improving Global Outcomes (KDIGO) CKD-MBD Work Group (ed): KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). 2009, 76:S1-130. 10.1038\/ki.2009.188"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2013.271","article-title":"Early chronic kidney disease-mineral bone disorder stimulates vascular calcification","volume":"85","author":"Fang Y","year":"2014","unstructured":"Fang Y, Ginsberg C, Sugatani T, Monier-Faugere MC, Malluche H, Hruska KA. Early chronic kidney disease-mineral bone disorder stimulates vascular calcification. Kidney Int. 2014, 85:142-50. 10.1038\/ki.2013.271","journal-title":"Kidney Int"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007010022","article-title":"Fracture risk after parathyroidectomy among chronic hemodialysis patients","volume":"18","author":"Rudser KD","year":"2007","unstructured":"Rudser KD, de Boer IH, Dooley A, Young B, Kestenbaum B. Fracture risk after parathyroidectomy among chronic hemodialysis patients. J Am Soc Nephrol. 2007, 18:2401-7. 10.1681\/ASN.2007010022","journal-title":"J Am Soc Nephrol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.4103\/ijem.IJEM_292_19","article-title":"Secondary and tertiary hyperparathyroidism in chronic kidney disease: an endocrine and renal perspective","volume":"23","author":"Chandran M","year":"2019","unstructured":"Chandran M, Wong J. Secondary and tertiary hyperparathyroidism in chronic kidney disease: an endocrine and renal perspective. Indian J Endocrinol Metab. 2019, 23:391-9. 10.4103\/ijem.IJEM_292_19","journal-title":"Indian J Endocrinol Metab"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.308","article-title":"Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis","volume":"305","author":"Palmer SC","year":"2011","unstructured":"Palmer SC, Hayen A, Macaskill P, Pellegrini F, Craig JC, Elder GJ, Strippoli GF. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA. 2011, 305:1119-27. 10.1001\/jama.2011.308","journal-title":"JAMA"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.06040614","article-title":"Comparison of fracture risk prediction among individuals with reduced and normal kidney function","volume":"10","author":"Naylor KL","year":"2015","unstructured":"Naylor KL, Garg AX, Zou G, et al.. Comparison of fracture risk prediction among individuals with reduced and normal kidney function. Clin J Am Soc Nephrol. 2015, 10:646-53. 10.2215\/CJN.06040614","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2013.279","article-title":"High rates of death and hospitalization follow bone fracture among hemodialysis patients","volume":"85","author":"Tentori F","year":"2014","unstructured":"Tentori F, McCullough K, Kilpatrick RD, Bradbury BD, Robinson BM, Kerr PG, Pisoni RL. High rates of death and hospitalization follow bone fracture among hemodialysis patients. Kidney Int. 2014, 85:166-73. 10.1038\/ki.2013.279","journal-title":"Kidney Int"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.03.069","article-title":"Vitamin D, parathyroid hormone, and cardiovascular events among older adults","volume":"58","author":"Kestenbaum B","year":"2011","unstructured":"Kestenbaum B, Katz R, de Boer I, et al.. Vitamin D, parathyroid hormone, and cardiovascular events among older adults. J Am Coll Cardiol. 2011, 58:1433-41. 10.1016\/j.jacc.2011.03.069","journal-title":"J Am Coll Cardiol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvs126","article-title":"Sources of cells that contribute to atherosclerotic intimal calcification: an in vivo genetic fate mapping study","volume":"94","author":"Naik V","year":"2012","unstructured":"Naik V, Leaf EM, Hu JH, Yang HY, Nguyen NB, Giachelli CM, Speer MY. Sources of cells that contribute to atherosclerotic intimal calcification: an in vivo genetic fate mapping study. Cardiovasc Res. 2012, 94:545-54. 10.1093\/cvr\/cvs126","journal-title":"Cardiovasc Res"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.108.183053","article-title":"Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries","volume":"104","author":"Speer MY","year":"2009","unstructured":"Speer MY, Yang HY, Brabb T, et al.. Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries. Circ Res. 2009, 104:733-41. 10.1161\/CIRCRESAHA.108.183053","journal-title":"Circ Res"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.12373","article-title":"BMP-9 regulates the osteoblastic differentiation and calcification of vascular smooth muscle cells through an ALK1 mediated pathway","volume":"19","author":"Zhu D","year":"2015","unstructured":"Zhu D, Mackenzie NC, Shanahan CM, Shroff RC, Farquharson C, MacRae VE. BMP-9 regulates the osteoblastic differentiation and calcification of vascular smooth muscle cells through an ALK1 mediated pathway. J Cell Mol Med. 2015, 19:165-74. 10.1111\/jcmm.12373","journal-title":"J Cell Mol Med"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.02.002","article-title":"Ligand trap for the activin type IIA receptor protects against vascular disease and renal fibrosis in mice with chronic kidney disease","volume":"89","author":"Agapova OA","year":"2016","unstructured":"Agapova OA, Fang Y, Sugatani T, Seifert ME, Hruska KA. Ligand trap for the activin type IIA receptor protects against vascular disease and renal fibrosis in mice with chronic kidney disease. Kidney Int. 2016, 89:1231-43. 10.1016\/j.kint.2016.02.002","journal-title":"Kidney Int"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfs598","article-title":"Correlates of parathyroid hormone concentration in hemodialysis patients","volume":"28","author":"Li J","year":"2013","unstructured":"Li J, Molnar MZ, Zaritsky JJ, et al.. Correlates of parathyroid hormone concentration in hemodialysis patients. Nephrol Dial Transplant. 2013, 28:1516-25. 10.1093\/ndt\/gfs598","journal-title":"Nephrol Dial Transplant"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe S","year":"2006","unstructured":"Moe S, Dr\u00fceke T, Cunningham J, et al.. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2006, 69:1945-53. 10.1038\/sj.ki.5000414","journal-title":"Kidney Int"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1161\/hy1001.096358","article-title":"Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease","volume":"38","author":"Blacher J","year":"2001","unstructured":"Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension. 2001, 38:938-42. 10.1161\/hy1001.096358","journal-title":"Hypertension"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002241","article-title":"Vascular calcification: contribution of parathyroid hormone in renal failure","volume":"71","author":"Neves KR","year":"2007","unstructured":"Neves KR, Graciolli FG, dos Reis LM, et al.. Vascular calcification: contribution of parathyroid hormone in renal failure. Kidney Int. 2007, 71:1262-70. 10.1038\/sj.ki.5002241","journal-title":"Kidney Int"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M308825200","article-title":"Teriparatide (human parathyroid hormone (1-34)) inhibits osteogenic vascular calcification in diabetic low density lipoprotein receptor-deficient mice","volume":"278","author":"Shao JS","year":"2003","unstructured":"Shao JS, Cheng SL, Charlton-Kachigian N, Loewy AP, Towler DA. Teriparatide (human parathyroid hormone (1-34)) inhibits osteogenic vascular calcification in diabetic low density lipoprotein receptor-deficient mice. J Biol Chem. 2003, 278:50195-202. 10.1074\/jbc.M308825200","journal-title":"J Biol Chem"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.06091108","article-title":"Association of serum alkaline phosphatase with coronary artery calcification in maintenance hemodialysis patients","volume":"4","author":"Shantouf R","year":"2009","unstructured":"Shantouf R, Kovesdy CP, Kim Y, et al.. Association of serum alkaline phosphatase with coronary artery calcification in maintenance hemodialysis patients. Clin J Am Soc Nephrol. 2009, 4:1106-14. 10.2215\/CJN.06091108","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2016.06.025","article-title":"Survival, risk factors, and effect of treatment in 101 patients with calciphylaxis","volume":"91","author":"McCarthy JT","year":"2016","unstructured":"McCarthy JT, El-Azhary RA, Patzelt MT, et al.. Survival, risk factors, and effect of treatment in 101 patients with calciphylaxis. Mayo Clin Proc. 2016, 91:1384-94. 10.1016\/j.mayocp.2016.06.025","journal-title":"Mayo Clin Proc"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv438","article-title":"Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry","volume":"32","author":"Brandenburg VM","year":"2017","unstructured":"Brandenburg VM, Kramann R, Rothe H, et al.. Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry. Nephrol Dial Transplant. 2017, 32:126-32. 10.1093\/ndt\/gfv438","journal-title":"Nephrol Dial Transplant"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1111\/1744-9987.12685","article-title":"Emerging association between parathyroid hormone and anemia in hemodialysis patients","volume":"22","author":"Tanaka M","year":"2018","unstructured":"Tanaka M, Komaba H, Fukagawa M. Emerging association between parathyroid hormone and anemia in hemodialysis patients. Ther Apher Dial. 2018, 22:242-5. 10.1111\/1744-9987.12685","journal-title":"Ther Apher Dial"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1159\/000013563","article-title":"Hyperparathyroidism and anemia in renal failure","volume":"20","author":"Gallieni M","year":"2000","unstructured":"Gallieni M, Corsi C, Brancaccio D. Hyperparathyroidism and anemia in renal failure. Am J Nephrol. 2000, 20:89-96. 10.1159\/000013563","journal-title":"Am J Nephrol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/13.10.2708","article-title":"Parathyroidectomy and response to erythropoietin therapy in anaemic patients with chronic renal failure","volume":"13","author":"Mandolfo S","year":"1998","unstructured":"Mandolfo S, Malberti F, Farina M, Villa G, Scanziani R, Surian M, Imbasciati E. Parathyroidectomy and response to erythropoietin therapy in anaemic patients with chronic renal failure. Nephrol Dial Transplant. 1998, 13:2708-9. 10.1093\/ndt\/13.10.2708","journal-title":"Nephrol Dial Transplant"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2016.1184924","article-title":"Long-term mortality after parathyroidectomy among chronic kidney disease patients with secondary hyperparathyroidism: a systematic review and meta-analysis","volume":"38","author":"Chen L","year":"2016","unstructured":"Chen L, Wang K, Yu S, Lai L, Zhang X, Yuan J, Duan W. Long-term mortality after parathyroidectomy among chronic kidney disease patients with secondary hyperparathyroidism: a systematic review and meta-analysis. Ren Fail. 2016, 38:1050-8. 10.1080\/0886022X.2016.1184924","journal-title":"Ren Fail"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02830608","article-title":"Lanthanum carbonate reduces phosphorus burden in patients with CKD stages 3 and 4: a randomized trial","volume":"4","author":"Sprague SM","year":"2009","unstructured":"Sprague SM, Abboud H, Qiu P, Dauphin M, Zhang P, Finn W. Lanthanum carbonate reduces phosphorus burden in patients with CKD stages 3 and 4: a randomized trial. Clin J Am Soc Nephrol. 2009, 4:178-85. 10.2215\/CJN.02830608","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref56","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","author":"National Kidney Foundation","year":"2003","unstructured":"National Kidney Foundation. K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003, 42:S1-201.","journal-title":"Am J Kidney Dis"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.06800615","article-title":"Sevelamer versus calcium-based binders for treatment of hyperphosphatemia in CKD: a meta-analysis of randomized controlled trials","volume":"11","author":"Patel L","year":"2016","unstructured":"Patel L, Bernard LM, Elder GJ. Sevelamer versus calcium-based binders for treatment of hyperphosphatemia in CKD: a meta-analysis of randomized controlled trials. Clin J Am Soc Nephrol. 2016, 11:232-44. 10.2215\/CJN.06800615","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2018101058","article-title":"Effects of nicotinamide and lanthanum carbonate on serum phosphate and fibroblast growth factor-23 in CKD: the COMBINE trial","volume":"30","author":"Ix JH","year":"2019","unstructured":"Ix JH, Isakova T, Larive B, et al.. Effects of nicotinamide and lanthanum carbonate on serum phosphate and fibroblast growth factor-23 in CKD: the COMBINE trial. J Am Soc Nephrol. 2019, 30:1096-108. 10.1681\/ASN.2018101058","journal-title":"J Am Soc Nephrol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2016.05.015","article-title":"Phosphate-binding agents in adults with CKD: a network meta-analysis of randomized trials","volume":"68","author":"Palmer SC","year":"2016","unstructured":"Palmer SC, Gardner S, Tonelli M, et al.. Phosphate-binding agents in adults with CKD: a network meta-analysis of randomized trials. Am J Kidney Dis. 2016, 68:691-702. 10.1053\/j.ajkd.2016.05.015","journal-title":"Am J Kidney Dis"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005633.pub2","article-title":"Vitamin D compounds for people with chronic kidney disease requiring dialysis","author":"Palmer SC","year":"2009","unstructured":"Palmer SC, McGregor DO, Craig JC, Elder G, Macaskill P, Strippoli GF. Vitamin D compounds for people with chronic kidney disease requiring dialysis. Cochrane Database Syst Rev. 2009, CD005633. 10.1002\/14651858.CD005633.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198908033210502","article-title":"Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure","volume":"321","author":"Andress DL","year":"1989","unstructured":"Andress DL, Norris KC, Coburn JW, Slatopolsky EA, Sherrard DJ. Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. N Engl J Med. 1989, 321:274-9. 10.1056\/NEJM198908033210502","journal-title":"N Engl J Med"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199810083391507","article-title":"Care of patients undergoing hemodialysis","volume":"339","author":"Ifudu O","year":"1998","unstructured":"Ifudu O. Care of patients undergoing hemodialysis. N Engl J Med. 1998, 339:1054-62. 10.1056\/NEJM199810083391507","journal-title":"N Engl J Med"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.81.4.8636374","article-title":"Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism","volume":"81","author":"Kifor O","year":"1996","unstructured":"Kifor O, Moore FD Jr, Wang P, et al.. Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab. 1996, 81:1598-606. 10.1210\/jcem.81.4.8636374","journal-title":"J Clin Endocrinol Metab"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfg451","article-title":"Relationship between parathyroid gland size and responsiveness to maxacalcitol therapy in patients with secondary hyperparathyroidism","volume":"18","author":"Okuno S","year":"2003","unstructured":"Okuno S, Ishimura E, Kitatani K, et al.. Relationship between parathyroid gland size and responsiveness to maxacalcitol therapy in patients with secondary hyperparathyroidism. Nephrol Dial Transplant. 2003, 18:2613-21. 10.1093\/ndt\/gfg451","journal-title":"Nephrol Dial Transplant"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02110310","article-title":"Cinacalcet effectively reduces parathyroid hormone secretion and gland volume regardless of pretreatment gland size in patients with secondary hyperparathyroidism","volume":"5","author":"Komaba H","year":"2010","unstructured":"Komaba H, Nakanishi S, Fujimori A, et al.. Cinacalcet effectively reduces parathyroid hormone secretion and gland volume regardless of pretreatment gland size in patients with secondary hyperparathyroidism. Clin J Am Soc Nephrol. 2010, 5:2305-14. 10.2215\/CJN.02110310","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.349","article-title":"Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism","volume":"87","author":"Behets GJ","year":"2015","unstructured":"Behets GJ, Spasovski G, Sterling LR, Goodman WG, Spiegel DM, De Broe ME, D'Haese PC. Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism. Kidney Int. 2015, 87:846-56. 10.1038\/ki.2014.349","journal-title":"Kidney Int"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1205624","article-title":"Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis","volume":"367","author":"Chertow GM","year":"2012","unstructured":"Chertow GM, Block GA, Correa-Rotter R, et al.. Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med. 2012, 367:2482-94. 10.1056\/NEJMoa1205624","journal-title":"N Engl J Med"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014040414","article-title":"Effects of cinacalcet on fracture events in patients receiving hemodialysis: the EVOLVE trial","volume":"26","author":"Moe SM","year":"2015","unstructured":"Moe SM, Abdalla S, Chertow GM, et al.. Effects of cinacalcet on fracture events in patients receiving hemodialysis: the EVOLVE trial. J Am Soc Nephrol. 2015, 26:1466-75. 10.1681\/ASN.2014040414","journal-title":"J Am Soc Nephrol"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gft417","article-title":"Velcalcetide (AMG 416), a novel peptide agonist of the calcium-sensing receptor, reduces serum parathyroid hormone and FGF23 levels in healthy male subjects","volume":"29","author":"Martin KJ","year":"2014","unstructured":"Martin KJ, Bell G, Pickthorn K, Huang S, Vick A, Hodsman P, Peacock M. Velcalcetide (AMG 416), a novel peptide agonist of the calcium-sensing receptor, reduces serum parathyroid hormone and FGF23 levels in healthy male subjects. Nephrol Dial Transplant. 2014, 29:385-92. 10.1093\/ndt\/gft417","journal-title":"Nephrol Dial Transplant"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.10390917","article-title":"Parathyroidectomy in the management of secondary hyperparathyroidism","volume":"13","author":"Lau WL","year":"2018","unstructured":"Lau WL, Obi Y, Kalantar-Zadeh K. Parathyroidectomy in the management of secondary hyperparathyroidism. Clin J Am Soc Nephrol. 2018, 13:952-61. 10.2215\/CJN.10390917","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0000000000000327","article-title":"Hungry bone syndrome","volume":"26","author":"Jain N","year":"2017","unstructured":"Jain N, Reilly RF. Hungry bone syndrome. Curr Opin Nephrol Hypertens. 2017, 26:250-5. 10.1097\/MNH.0000000000000327","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-12-0528","article-title":"Hungry bone syndrome: still a challenge in the post-operative management of primary hyperparathyroidism: a systematic review of the literature","volume":"168","author":"Witteveen JE","year":"2013","unstructured":"Witteveen JE, van Thiel S, Romijn JA, Hamdy NA. Hungry bone syndrome: still a challenge in the post-operative management of primary hyperparathyroidism: a systematic review of the literature. Eur J Endocrinol. 2013, 168:R45-53. 10.1530\/EJE-12-0528","journal-title":"Eur J Endocrinol"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174811","article-title":"The shift from high to low turnover bone disease after parathyroidectomy is associated with the progression of vascular calcification in hemodialysis patients: a 12-month follow-up study","volume":"12","author":"Hernandes FR","year":"2017","unstructured":"Hernandes FR, Canziani ME, Barreto FC, Santos RO, Moreira VM, Rochitte CE, Carvalho AB. The shift from high to low turnover bone disease after parathyroidectomy is associated with the progression of vascular calcification in hemodialysis patients: a 12-month follow-up study. PLoS One. 2017, 12:e0174811. 10.1371\/journal.pone.0174811","journal-title":"PLoS One"},{"key":"ref74","article-title":"Ultrasound-guided percutaneous fine-needle ethanol injection into parathyroid glands in secondary hyperparathyroidism","volume":"7","author":"Giangrande A","year":"1992","unstructured":"Giangrande A, Castiglioni A, Solbiati L, Allaria P. Ultrasound-guided percutaneous fine-needle ethanol injection into parathyroid glands in secondary hyperparathyroidism. Nephrol Dial Transplant. 1992, 7:412-21.","journal-title":"Nephrol Dial Transplant"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfg1008","article-title":"Guidelines for percutaneous ethanol injection therapy of the parathyroid glands in chronic dialysis patients","volume":"18 Suppl 3","author":"Fukagawa M","year":"2003","unstructured":"Fukagawa M, Kitaoka M, Tominaga Y, et al.. Guidelines for percutaneous ethanol injection therapy of the parathyroid glands in chronic dialysis patients. Nephrol Dial Transplant. 2003, 18 Suppl 3:iii31-3. 10.1093\/ndt\/gfg1008","journal-title":"Nephrol Dial Transplant"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfg1012","article-title":"Efficacy of direct injection of calcitriol into the parathyroid glands in uraemic patients with moderate to severe secondary hyperparathyroidism","volume":"18 Suppl 3","author":"Nakanishi S","year":"2003","unstructured":"Nakanishi S, Yano S, Nomura R, Tsukamoto T, Shimizu Y, Shin J, Fukagawa M. Efficacy of direct injection of calcitriol into the parathyroid glands in uraemic patients with moderate to severe secondary hyperparathyroidism. Nephrol Dial Transplant. 2003, 18 Suppl 3:iii47-9. 10.1093\/ndt\/gfg1012","journal-title":"Nephrol Dial Transplant"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.00938.x","article-title":"Early calcification of renal allografts detected by protocol biopsies: causes and clinical implications","volume":"5","author":"Gwinner W","year":"2005","unstructured":"Gwinner W, Suppa S, Mengel M, Hoy L, Kreipe HH, Haller H, Schwarz A. Early calcification of renal allografts detected by protocol biopsies: causes and clinical implications. Am J Transplant. 2005, 5:1934-41. 10.1111\/j.1600-6143.2005.00938.x","journal-title":"Am J Transplant"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00303.x","article-title":"Clinical impact of preexisting vascular calcifications on mortality after renal transplantation","volume":"67","author":"Hern\u00e1ndez D","year":"2005","unstructured":"Hern\u00e1ndez D, Rufino M, Bartolomei S, Gonz\u00e1lez-Rinne A, Lorenzo V, Cobo M, Torres A. Clinical impact of preexisting vascular calcifications on mortality after renal transplantation. Kidney Int. 2005, 67:2015-20. 10.1111\/j.1523-1755.2005.00303.x","journal-title":"Kidney Int"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.6002\/ect.2016.0342","article-title":"Long-term use of cinacalcet in kidney transplant recipients with hypercalcemic secondary hyperparathyroidism: a single-center prospective study","volume":"16","author":"Zavvos V","year":"2018","unstructured":"Zavvos V, Fyssa L, Papasotiriou M, Papachristou E, Ntrinias T, Savvidaki E, Goumenos DS. Long-term use of cinacalcet in kidney transplant recipients with hypercalcemic secondary hyperparathyroidism: a single-center prospective study. Exp Clin Transplant. 2018, 16:287-93. 10.6002\/ect.2016.0342","journal-title":"Exp Clin Transplant"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/64402-secondary-hyperparathyroidism-in-chronic-kidney-disease-pathophysiology-and-management","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:32:44Z","timestamp":1707507164000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/64402-secondary-hyperparathyroidism-in-chronic-kidney-disease-pathophysiology-and-management"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,14]]},"references-count":79,"URL":"https:\/\/doi.org\/10.7759\/cureus.16388","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,14]]}}}